Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo

M. Romano, W. H. Polk, J. A. Awad, C. L. Arteaga, L. B. Nanney, M. J. Wargovich, E. R. Kraus, C. R. Boland, R. J. Coffey

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

This study was designed to determine whether transforming growth factor α (TGFα) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGFα dose-dependently decreased 100% ethanol-induced gastric mucosal injury; a dose of 50 μg/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90%. At the microscopic level, TGFα prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGFα (200 μg/kg) only partially (40%) decreased macroscopic ethanol damage. Intraperitoneal administration of TGFα at a dose of 10 μg/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80%. TGFα protection does not seem to be mediated by prostaglandin, glutathione, or ornithine decarboxylase-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40%) the protective effect of TGFα. In addition, systemic administration of TGFα resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGFα.

Original languageEnglish (US)
Pages (from-to)2409-2421
Number of pages13
JournalJournal of Clinical Investigation
Volume90
Issue number6
StatePublished - Dec 1 1992

Fingerprint

Transforming Growth Factors
Gastric Mucosa
Wounds and Injuries
Pharmaceutical Preparations
Ethanol
Aspirin
Stomach
Gastric Mucins
Phospholipase C gamma
Ethylmaleimide
Ornithine Decarboxylase
Gastric Acid
Prostaglandins
Glutathione
Tyrosine
Epithelium
Phosphorylation

Keywords

  • aspirin
  • ethanol
  • prostaglandin
  • sulfhydryl
  • transforming growth factor α

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Romano, M., Polk, W. H., Awad, J. A., Arteaga, C. L., Nanney, L. B., Wargovich, M. J., ... Coffey, R. J. (1992). Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo. Journal of Clinical Investigation, 90(6), 2409-2421.

Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo. / Romano, M.; Polk, W. H.; Awad, J. A.; Arteaga, C. L.; Nanney, L. B.; Wargovich, M. J.; Kraus, E. R.; Boland, C. R.; Coffey, R. J.

In: Journal of Clinical Investigation, Vol. 90, No. 6, 01.12.1992, p. 2409-2421.

Research output: Contribution to journalArticle

Romano, M, Polk, WH, Awad, JA, Arteaga, CL, Nanney, LB, Wargovich, MJ, Kraus, ER, Boland, CR & Coffey, RJ 1992, 'Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo', Journal of Clinical Investigation, vol. 90, no. 6, pp. 2409-2421.
Romano, M. ; Polk, W. H. ; Awad, J. A. ; Arteaga, C. L. ; Nanney, L. B. ; Wargovich, M. J. ; Kraus, E. R. ; Boland, C. R. ; Coffey, R. J. / Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo. In: Journal of Clinical Investigation. 1992 ; Vol. 90, No. 6. pp. 2409-2421.
@article{621f309267594b279b1efc8c9d6d99c6,
title = "Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo",
abstract = "This study was designed to determine whether transforming growth factor α (TGFα) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGFα dose-dependently decreased 100{\%} ethanol-induced gastric mucosal injury; a dose of 50 μg/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90{\%}. At the microscopic level, TGFα prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGFα (200 μg/kg) only partially (40{\%}) decreased macroscopic ethanol damage. Intraperitoneal administration of TGFα at a dose of 10 μg/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80{\%}. TGFα protection does not seem to be mediated by prostaglandin, glutathione, or ornithine decarboxylase-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40{\%}) the protective effect of TGFα. In addition, systemic administration of TGFα resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGFα.",
keywords = "aspirin, ethanol, prostaglandin, sulfhydryl, transforming growth factor α",
author = "M. Romano and Polk, {W. H.} and Awad, {J. A.} and Arteaga, {C. L.} and Nanney, {L. B.} and Wargovich, {M. J.} and Kraus, {E. R.} and Boland, {C. R.} and Coffey, {R. J.}",
year = "1992",
month = "12",
day = "1",
language = "English (US)",
volume = "90",
pages = "2409--2421",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo

AU - Romano, M.

AU - Polk, W. H.

AU - Awad, J. A.

AU - Arteaga, C. L.

AU - Nanney, L. B.

AU - Wargovich, M. J.

AU - Kraus, E. R.

AU - Boland, C. R.

AU - Coffey, R. J.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - This study was designed to determine whether transforming growth factor α (TGFα) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGFα dose-dependently decreased 100% ethanol-induced gastric mucosal injury; a dose of 50 μg/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90%. At the microscopic level, TGFα prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGFα (200 μg/kg) only partially (40%) decreased macroscopic ethanol damage. Intraperitoneal administration of TGFα at a dose of 10 μg/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80%. TGFα protection does not seem to be mediated by prostaglandin, glutathione, or ornithine decarboxylase-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40%) the protective effect of TGFα. In addition, systemic administration of TGFα resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGFα.

AB - This study was designed to determine whether transforming growth factor α (TGFα) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGFα dose-dependently decreased 100% ethanol-induced gastric mucosal injury; a dose of 50 μg/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90%. At the microscopic level, TGFα prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGFα (200 μg/kg) only partially (40%) decreased macroscopic ethanol damage. Intraperitoneal administration of TGFα at a dose of 10 μg/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80%. TGFα protection does not seem to be mediated by prostaglandin, glutathione, or ornithine decarboxylase-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40%) the protective effect of TGFα. In addition, systemic administration of TGFα resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGFα.

KW - aspirin

KW - ethanol

KW - prostaglandin

KW - sulfhydryl

KW - transforming growth factor α

UR - http://www.scopus.com/inward/record.url?scp=0027054057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027054057&partnerID=8YFLogxK

M3 - Article

C2 - 1281834

AN - SCOPUS:0027054057

VL - 90

SP - 2409

EP - 2421

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -